Real-World Data Show Unmet Need in KRAS p.G12C-Mutated Metastatic Colorectal Cancer
Treatment patterns are generally similar for patients with metastatic colorectal cancer (mCRC), whether or not they have KRAS p.G12C mutations, according to a real-world study published in The Oncologist. The data also showed numerically shorter overall survival (OS) and real-world progression-free survival (rwPFS) among patients with KRAS p.G12C mutations. “These patients appear to have poor…